13D·WATCH Activist + Insider Intelligence Live feed Blog About Pilot
SCHEDULE Filed 2025-05-14 Event 2025-05-12 SEC 0001140361-25-019024 →

KKR Genetic Disorder L.P. BridgeBio Pharma, Inc. BBIO

Stake: 7.00% Shares: 13,260,971 CUSIP: 10806X102 Class: Common Stock, par value $0.001 per share

Item 4 — Purpose of Transaction

Item 4 of the Schedule 13D is hereby amended and supplemented as follows: The information set forth in Item 5(c) below is incorporated by reference herein.

Cross-References

Insider Activity (last 365d)
0 transactions
0 buys · 0 sales · 0 awards/exercises
Issuer Cluster
8 13D/G filings on this issuer
7 other filings besides this one
Filer Track Record
3 filings by this filer
2 other filings in the data moat
Short Interest · settle 2026-03-31
DTC 14.73
23,366,752 shares short · -0.6% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers
1 holder · $581K
Point72 Asset Mgmt

Post-Filing Returns · since 2025-05-12 on BBIO

+1 day
-6.8%
+5 days
-5.6%
+30 days
+9.4%
+60 days
+30.2%
+90 days
+35.2%
+180 days
+76.0%

Anchor price 35.68 on closest trading day on/after 2025-05-12. Source: Yahoo Finance daily adj_close (split + dividend adjusted).

Other 13D/G Filings on BridgeBio Pharma, Inc.

FiledFormFilerStakeShares
2026-04-02 SCHEDULE 13D/A VIKING GLOBAL INVESTORS LP 6.10% 11,842,434 view →
2025-07-01 SCHEDULE VIKING GLOBAL INVESTORS LP 9.80% 18,602,920 view →
2025-03-07 SCHEDULE KKR Genetic Disorder L.P. 10.10% 19,260,971 view →
2025-01-31 SCHEDULE VIKING GLOBAL INVESTORS LP 11.70% 22,055,375 view →
2023-07-20 SC VIKING GLOBAL INVESTORS LP view →
2021-01-26 SC Eidos Therapeutics, Inc. view →
2020-06-01 SC KKR Genetic Disorder L.P. view →

Other Filings by KKR Genetic Disorder L.P.

FiledFormIssuerStakeShares
2025-03-07 SCHEDULE BridgeBio Pharma, Inc. BBIO 10.10% 19,260,971 view →
2020-06-01 SC BridgeBio Pharma, Inc. BBIO view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →